Search Results - Kurt de Vlam
- Showing 1 - 4 results of 4
-
1
Evolution of patient demographics, baseline clinical characteristics and outcomes in Phase 3 trials of biologics (TNFi, IL12/23i, IL17i, IL23i), PDE4i and TYK2i for psoriasis by Sara Peeters, Kurt De Vlam, Hugo Boonen, Canan Güvenç, Tom Hillary
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Resolution of therapy-resistant pyoderma gangrenosum with upadacitinib by Lisa Van Eycken, MD, Anne-Catherine Dens, MD, Kurt de Vlam, MD, PhD, Barbara Neerinckx, MD, PhD, Petra De Haes, MD, PhD
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity by April W. Armstrong, Tarannum Jaleel, Joseph F. Merola, Alice B. Gottlieb, Saakshi Khattri, Cameron C. Helt, William N. Malatestinic, Sarah E. Ross, Marcus E. Ngantcha, Kurt de Vlam
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity by April W. Armstrong, Tarannum Jaleel, Joseph F. Merola, Alice B. Gottlieb, Saakshi Khattri, Cameron C. Helt, William N. Malatestinic, Sarah E. Ross, Marcus E. Ngantcha, Kurt de Vlam
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book